AACP
TECH icon

Advantage Alpha Capital Partners’s Bio-Techne TECH Stock Holding History

Advantage Alpha Capital Partners’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-117,424
Closed -$7.27M – 115
2020
Q3 		$7.27M Buy
117,424
+84,396
+256% +$5.49M 1.68% 15
2020
Q2 		$2.18M Sell
33,028
-49,520
-60% -$2.97M 0.51% 85
2020
Q1 		$3.91M Buy
+82,548
New +$4.13M 1.39% 24

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Advantage Alpha Capital Partners's TECH Position: Q4 2020 in Review

Advantage Alpha Capital Partners sold out of Bio-Techne (TECH) in Q4 2020, closing a stake of 117,424 shares — an estimated $7.27M sold.

Advantage Alpha Capital Partners first reported a position in TECH in Q1 2020 and held it in 3 quarters. The position peaked at $7.27M in Q3 2020. 441 funds tracked by Wall St. Rank hold TECH as of Q4 2020.

  • Advantage Alpha Capital Partners reported no remaining Bio-Techne position as of Q4 2020 after selling out during the quarter.
  • Advantage Alpha Capital Partners sold 117,424 Bio-Techne shares in Q4 2020, an estimated $7.27M.
  • Advantage Alpha Capital Partners first reported a position in Bio-Techne in Q1 2020 and held it in 3 quarters.
  • Advantage Alpha Capital Partners's Bio-Techne position peaked at $7.27M in Q3 2020.
  • 441 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2020.

Based on Advantage Alpha Capital Partners's 13F filing for Q4 2020, filed 16 Feb 2021.